about
How to Establish Clinical Prediction ModelsInverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetesAnatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011)Screening for prediabetes using machine learning models.Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese mice.Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from KoreaEffects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data.Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucoseRosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008-2011).Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness.Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study.Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008-2009.Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study.Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.Fasting Glucose and All-Cause Mortality by Age in Diabetes: A Prospective Cohort Study.ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus.Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin.Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer.Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in KoreaThe combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011SGLT2 inhibitor regulates ketone body metabolism via inter-organ crosstalkDifferential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort studyLow-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampusGrowth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in miceSarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis BDifferential association of body mass index on glycemic control in type 1 diabetes
P50
Q26753186-D7C3ACE7-D977-4112-828F-AE14E4CFC71FQ28543379-2694E034-F318-4327-A3DC-62265D9743EEQ33604348-EDF62819-0124-4C82-B17E-8B24CCC634F1Q34073331-3469D9B8-1BB7-43F5-9D7A-D67D2DEC1077Q34172798-2BCCD58E-52BA-407C-A6FF-0A9A3F8AC574Q34506664-E47E7DAD-20F5-4795-A0EC-9981F7A1A633Q35790625-CDD17140-3924-4352-A7CB-F7295CB849A2Q35956522-6143DA63-A0F2-4071-90CF-CB3F027EEB3AQ36005146-D0957F32-C1C0-4303-98A2-F7A5EF757712Q36052533-02B47339-E1CE-4713-9298-05AADC5CCEC1Q36246346-7FF699D2-D985-4191-8ED0-FD30C1B48E83Q36274187-E9B4ECD8-0585-47F8-AFC9-8D41EA643477Q36581133-723499AC-48A5-4E91-94A4-69697D586F43Q36810011-6C805B6D-498D-4276-A608-56015C958A89Q37212036-EFB5B493-982D-43A0-A126-EE4D6BFD82C6Q37482466-CEA1DFA4-E0B9-4AFF-B113-59933BA2FB6BQ39383977-E47516D5-C1A1-466A-947E-C321EB4DE3FDQ40081969-E1F8B8D7-38AE-4EE7-82A0-2B521D878726Q40468893-7A595161-C979-4D95-9DBC-382463813A39Q41921761-73318E2B-CE8E-4A30-8D8E-6A869242711BQ43665486-42AA5222-0A66-4CCA-89A4-10CD599B5544Q47156332-E9A88DE0-4726-4E31-B621-0BBE356A0108Q47382207-B95B8485-8E9A-4878-B734-63097FD6ED89Q47768810-E9163809-4F4C-499E-8B18-0067F6941641Q48307335-C1FA6AC8-90E4-41D9-B676-D2C4EB7AF348Q49223170-5A624E77-3E81-41D3-BA27-C5F9CDD0ADD8Q49635002-9DE17166-6D36-4807-A47F-D81C3B5F1D31Q52573376-1C1A1F87-D9DC-457A-B5D8-044C58A6D06AQ53357837-25CE030C-0BCB-497B-B240-0B420B91B4AEQ54935754-E78F4FC3-02DF-4180-9923-4C619CD2C053Q55340247-E4C08847-0CE7-4751-A0E8-E03F6A6C86B4Q57213589-A3743A05-1CA1-48AA-B595-C61906B764DFQ57215000-C39E4C97-F280-4166-9EDB-92796C5BBE22Q57222313-2F680C04-CA57-417E-80D3-52E357E6F81AQ58578882-9686DEA9-0057-45A2-86FC-E3BF9FF8887EQ58793824-2C9D5583-08D1-413A-B486-7F15FFEC452FQ64100296-04732EF7-319A-42F7-89EB-49FC41171E48Q88537974-AE065153-849A-49DE-9113-665DF65DC5B7Q89153286-4C2F8FD8-B334-4296-A890-0DC27869E752Q89388938-B513EEC7-97C8-44BD-869A-31DD687DC8D1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yong-Ho Lee
@ast
Yong-Ho Lee
@en
Yong-Ho Lee
@es
Yong-Ho Lee
@nl
type
label
Yong-Ho Lee
@ast
Yong-Ho Lee
@en
Yong-Ho Lee
@es
Yong-Ho Lee
@nl
prefLabel
Yong-Ho Lee
@ast
Yong-Ho Lee
@en
Yong-Ho Lee
@es
Yong-Ho Lee
@nl
P106
P1153
56182910900
P31
P496
0000-0002-6219-4942